Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Evaluation of Vitrase as a Spreading Agent

ClinicalTrials.gov ID: NCT00198484

Public ClinicalTrials.gov record NCT00198484. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 1:19 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Evaluation of Vitrase (Hyaluronidase for Injection) Ovine, 200 USP Units/mL, as an Adjuvant to Increase the Absorption and Dispersion of Other Injected Drugs Prior to Ocular Surgery

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether Vitrase (hyaluronidase for injection) is effective as a spreading agent for other injected drugs prior to ocular surgery

Study identification

NCT ID
NCT00198484
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bausch & Lomb Incorporated
Industry
Enrollment
108 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2004 (Type not available)
Primary completion
Dec 2004 (Actual)
Completion
Feb 2005 (Actual)
Last update posted
Mar 14, 2013

2004 – 2005

United States locations

U.S. sites
18
U.S. states
12
U.S. cities
18
Facility City State ZIP Site status
David Wirta, MD, Inc. Newport Beach California 92663 —
Richard A Lewis, MD Sacramento California 95815 —
E Randy Craven, MD Littleton Colorado 80120 —
The Eye Care Group New Haven Connecticut 06510 —
Advanced Eye Care, PC Fort Oglethorpe Georgia 30742 —
Donald E Beahm, MD Great Bend Kansas 67530 —
Cincinnati Eye Institute NKY Edgewood Kentucky 41017 —
Cornea Consultants Boston Massachusetts 02114 —
Hunkeler Eye Institute Kansas City Missouri 64111 —
Ophthalmic Consultants of Long Island Rockville Centre New York 11570 —
David L Schwartz, MD Tulsa Oklahoma 74104 —
Black Hills Regional Eye Institute Rapid City South Dakota 57701 —
Texan Eye Care PA Austin Texas 78705 —
Ophthalmology Service, Brooke Army Medical Center Fort Sam Houston Texas 78234 —
Ophthalmology Visual Science Galveston Texas 77555 —
Houston Eye Associates Houston Texas 77025 —
David G Shulman, MD San Antonio Texas 78209 —
Central Texas Eye Center San Marcos Texas 78666 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00198484, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 14, 2013 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00198484 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →